AroCell signs distribution agreement with Gongyingshi in China for AroCell TK 210 ELISA
January 15, 2019 02:00 ET
|
AroCell AB
AroCell AB (publ) announced today that a distribution agreement has been signed with the Beijing based company Gongyingshi for the promotion and distribution of the AroCell TK 210™ ELISA in China. ...
Ny vetenskaplig artikel från AroCell som konfirmerar värdet avTK 210 ELISA som verktyg inom läkemedelsutveckling och pre-klinisk forskning
December 11, 2018 02:30 ET
|
AroCell AB
AroCell AB (publ) meddelar idag att en vetenskaplig artikel med titeln ” Doxorubicin effects on leukemia and breast cancer cells in culture on the Thymidine Kinase 1 protein levels using AroCell...
A new scientific publication from AroCell confirming the value of AroCell TK 210 ELISA as a tool in drug discovery and development
December 11, 2018 02:30 ET
|
AroCell AB
A peer-reviewed article has been published in the journal Nucleosides, Nucleotides and Nucleic Acids, entitled “Doxorubicin effects on leukemia and breast cancer cells in culture on the Thymidine...
New Publication from AroCell AB Demonstrating the Value of Thymidine Kinase 1 as a Tumor Biomarker
August 24, 2018 07:50 ET
|
AroCell AB
A new review article has been published, Thymidine Kinase 1 as a tumor biomarker: technical advances offer new potential to an old biomarker, that analyses and summarizes recent publications...
NOTICE TO DISREGARD - SOHM, Inc.
August 09, 2018 12:14 ET
|
SOHM, Inc.
Chino Hills, CA, Aug. 09, 2018 (GLOBE NEWSWIRE) -- We are advised by SOHM, Inc. (PINKSHEETS: SHMN) that journalists and other readers should disregard the news release, "SOHM, Inc. Subsidiary...
Groupe Santé Devonian annonce la signature d’une lettre d’intention non contraignante avec Folia Biotech pour le développement du FB-631 en immunothérapie pour le cancer
June 28, 2018 08:45 ET
|
Groupe Santé Devonian Inc.
QUÉBEC, Québec, 28 juin 2018 (GLOBE NEWSWIRE) -- Groupe Santé Devonian inc. (« Devonian » ou la « Société ») (TSX CROISSANCE:GSD) a annoncé aujourd'hui la signature d'une lettre...
Devonian Announces the Signing of a Non-Binding Letter of Intent with Folia Biotech to develop FB-631 in cancer immunotherapy
June 28, 2018 08:45 ET
|
Devonian Health Group Inc.
QUEBEC CITY, Quebec, June 28, 2018 (GLOBE NEWSWIRE) -- Devonian Health Group Inc. ("Devonian" or the "Corporation") (TSX VENTURE:GSD) and Folia Biotech inc. (‘‘Folia’’) today announce the signing of...
UFCW Canada union members raise $2.5 million for the Leukemia and Lymphoma Society of Canada
June 14, 2018 11:58 ET
|
UFCW Canada
TORONTO, June 14, 2018 (GLOBE NEWSWIRE) -- The tremendous fundraising efforts of UFCW Canada (United Food and Commercial Workers union) members and Local Unions over the past year have once again...
MEDIA ADVISORY: Major donation from UFCW Canada to be presented June 13 to Leukemia and Lymphoma Society of Canada to accelerate advancements in blood cancer treatments
June 12, 2018 16:32 ET
|
UFCW Canada
TORONTO, June 12, 2018 (GLOBE NEWSWIRE) -- On Wednesday, June 13, 2018, UFCW Canada (United Food and Commercial Workers union) will be presenting its annual fundraising donation to the Leukemia and...
Midatech Pharma US enrols first patient in Gelclair trial in stem cell transplant
June 08, 2018 02:00 ET
|
Midatech Pharma Plc
8 June 2018 Midatech Pharma PLC(“Midatech”, “Company” or “Group”) Midatech Pharma US enrols first patient in Gelclair® trial in stem cell transplant Patients now being enrolled at the...